在寨卡病毒战略中使用纳米生物技术的技术情景

IF 1.6 Q2 INFORMATION SCIENCE & LIBRARY SCIENCE

COLLNET Journal of Scientometrics and Information Management Pub Date : 2021-07-03 DOI:10.1080/09737766.2021.1981172

Jânio Rodrigo de Jesus Santos, Cláudio Damasceno Pinto, Angela Machado Rocha

{"title":"在寨卡病毒战略中使用纳米生物技术的技术情景","authors":"Jânio Rodrigo de Jesus Santos, Cláudio Damasceno Pinto, Angela Machado Rocha","doi":"10.1080/09737766.2021.1981172","DOIUrl":null,"url":null,"abstract":"Nanobiotechnology is a promising area of research that has been used to develop technologies to combat Zika virus (ZIKV). This study aims to analyze the patent scenario related to the use of nanobiotechnology in strategies against the ZIKV, using the Orbit Intelligence software. The results point to growth in the number of patent deposits between the years 2015 and 2019. Modernatx, MIT, and Harvard University own 38% of the technologies developed against the ZIKV. The EPO, WIPO, and the United States received 47% of patent protection applications developed by companies with support from techniques in the fields of pharmacology and biotechnology. About 42% of patents found belong to the areas of diagnosis and prevention, designed with the aid of nanoparticles used as delivery systems in vaccines and rapid tests. The results showed that nanobiotechnology is an emerging technology and has been widely used in strategies to stop the ZIKV advance.","PeriodicalId":10501,"journal":{"name":"COLLNET Journal of Scientometrics and Information Management","volume":"15 1","pages":"413 - 428"},"PeriodicalIF":1.6000,"publicationDate":"2021-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Technological scenarios of the use of nanobiotechnology in strategies against Zika virus\",\"authors\":\"Jânio Rodrigo de Jesus Santos, Cláudio Damasceno Pinto, Angela Machado Rocha\",\"doi\":\"10.1080/09737766.2021.1981172\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Nanobiotechnology is a promising area of research that has been used to develop technologies to combat Zika virus (ZIKV). This study aims to analyze the patent scenario related to the use of nanobiotechnology in strategies against the ZIKV, using the Orbit Intelligence software. The results point to growth in the number of patent deposits between the years 2015 and 2019. Modernatx, MIT, and Harvard University own 38% of the technologies developed against the ZIKV. The EPO, WIPO, and the United States received 47% of patent protection applications developed by companies with support from techniques in the fields of pharmacology and biotechnology. About 42% of patents found belong to the areas of diagnosis and prevention, designed with the aid of nanoparticles used as delivery systems in vaccines and rapid tests. The results showed that nanobiotechnology is an emerging technology and has been widely used in strategies to stop the ZIKV advance.\",\"PeriodicalId\":10501,\"journal\":{\"name\":\"COLLNET Journal of Scientometrics and Information Management\",\"volume\":\"15 1\",\"pages\":\"413 - 428\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2021-07-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"COLLNET Journal of Scientometrics and Information Management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/09737766.2021.1981172\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"INFORMATION SCIENCE & LIBRARY SCIENCE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"COLLNET Journal of Scientometrics and Information Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/09737766.2021.1981172","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFORMATION SCIENCE & LIBRARY SCIENCE","Score":null,"Total":0}

引用次数: 0

摘要

纳米生物技术是一个很有前途的研究领域，已被用于开发对抗寨卡病毒(ZIKV)的技术。本研究旨在利用Orbit Intelligence软件，分析与纳米生物技术在对抗寨卡病毒策略中的应用相关的专利情况。结果表明，2015年至2019年期间，专利保证金数量有所增长。现代科技、麻省理工学院和哈佛大学拥有对抗寨卡病毒的38%的技术。在药理学和生物技术领域的技术支持下，欧洲专利局、世界知识产权组织和美国收到了47%的公司开发的专利保护申请。发现的专利中约有42%属于诊断和预防领域，这些领域的设计借助纳米粒子作为疫苗和快速检测的递送系统。结果表明，纳米生物技术是一项新兴技术，已广泛应用于阻止寨卡病毒传播的策略中。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Technological scenarios of the use of nanobiotechnology in strategies against Zika virus

Nanobiotechnology is a promising area of research that has been used to develop technologies to combat Zika virus (ZIKV). This study aims to analyze the patent scenario related to the use of nanobiotechnology in strategies against the ZIKV, using the Orbit Intelligence software. The results point to growth in the number of patent deposits between the years 2015 and 2019. Modernatx, MIT, and Harvard University own 38% of the technologies developed against the ZIKV. The EPO, WIPO, and the United States received 47% of patent protection applications developed by companies with support from techniques in the fields of pharmacology and biotechnology. About 42% of patents found belong to the areas of diagnosis and prevention, designed with the aid of nanoparticles used as delivery systems in vaccines and rapid tests. The results showed that nanobiotechnology is an emerging technology and has been widely used in strategies to stop the ZIKV advance.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

COLLNET Journal of Scientometrics and Information Management INFORMATION SCIENCE & LIBRARY SCIENCE-

自引率

0.00%

发文量